HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiyao He Selected Research

Neoplasms (Cancer)

11/2021Recent advances in lentiviral vectors for gene therapy.
1/2021CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.
1/2017Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis.
1/2016Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRĪ±.
7/2015CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy.
2/2014Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
10/2012Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiyao He Research Topics

Disease

7Neoplasms (Cancer)
11/2021 - 10/2012
4Inflammation (Inflammations)
01/2020 - 02/2015
3COVID-19
01/2022 - 01/2020
3Necrosis
01/2020 - 02/2015
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2022
1Leukemia
11/2021
1Chronic Renal Insufficiency
11/2021
1Severe combined immunodeficiency due to adenosine deaminase deficiency
11/2021
1Thalassemia
11/2021
1Coronavirus Infections
01/2020
1Severe Acute Respiratory Syndrome
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Rupture
01/2020
1Animal Disease Models
01/2019
1Atherosclerosis
01/2019
1Atherosclerotic Plaque (Atheroma)
01/2019
1Bites and Stings (Sting)
01/2018
1Bone Fractures (Bone Fracture)
01/2018
1Pneumonia (Pneumonitis)
01/2017
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017
1Cystic Fibrosis (Mucoviscidosis)
01/2017
1Skin Diseases (Skin Disease)
01/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016
1Breast Neoplasms (Breast Cancer)
02/2014
1Neoplasm Metastasis (Metastasis)
02/2014
1Glaucoma
10/2013
1Ovarian Neoplasms (Ovarian Cancer)
05/2013
1Carcinoma (Carcinomatosis)
05/2013

Drug/Important Bio-Agent (IBA)

5Liposomes (Liposome)IBA
01/2020 - 05/2013
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2020 - 05/2013
3Mitochondrial DNA (mtDNA)IBA
01/2020 - 02/2015
3CholesterolIBA
01/2019 - 10/2012
2Antiviral Agents (Antivirals)IBA
01/2022 - 01/2020
2monomethoxypolyethylene glycol (MPEG)IBA
05/2013 - 10/2012
1remdesivirIBA
01/2022
1Histones (Histone)IBA
01/2022
1pembrolizumabIBA
01/2022
1GlobinsIBA
11/2021
1Adenosine DeaminaseIBA
11/2021
1Proton Pump InhibitorsIBA
11/2021
1CRISPR-Associated Protein 9IBA
01/2021
1Cathepsin BIBA
01/2020
1VaccinesIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1SootIBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1olaparibIBA
01/2020
1Folate Receptor 2IBA
01/2019
1Telmisartan (Micardis)FDA Link
01/2019
1Apolipoproteins E (ApoE)IBA
01/2019
1CollagenIBA
01/2019
1LipidsIBA
01/2019
1Collagenases (Collagenase)FDA Link
01/2019
1Matrix Metalloproteinases (MMPs)IBA
01/2019
1Therapeutic UsesIBA
01/2019
1Angiotensin Receptor AntagonistsIBA
01/2019
1Dinoprostone (PGE2)FDA Link
01/2018
1Complementary DNA (cDNA)IBA
01/2018
1Connective Tissue Growth FactorIBA
01/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2017
1indium-bleomycinIBA
01/2017
1protein kinase PIBA
01/2017
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2017
1EnzymesIBA
07/2015
1CationsIBA
02/2015
1Ouabain (G Strophanthin)IBA
02/2015
1Adenosine Triphosphatases (ATPase)IBA
02/2015
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
02/2014
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2014
1PD 173074IBA
02/2014
1Carbonic Anhydrase InhibitorsIBA
10/2013
1brinzolamide (Azopt)FDA Link
10/2013
1Folate Receptor 1IBA
05/2013
11,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
05/2013
1MicellesIBA
10/2012
1QuercetinIBA
10/2012
1Ethylene Glycol (Monoethylene Glycol)IBA
10/2012
1Pharmaceutical PreparationsIBA
10/2012

Therapy/Procedure

10Therapeutics
01/2022 - 05/2013
2Immunotherapy
01/2021 - 01/2020
1Drug Therapy (Chemotherapy)
01/2022
1Intraperitoneal Injections
01/2016
1Chemoprevention
10/2012